BlackRock Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $314M | Buy |
1,107,758
+158,870
| +17% | +$45.1M | 0.36% | 45 |
|
2016
Q3 | $297M | Buy |
948,888
+398,171
| +72% | +$125M | 0.37% | 48 |
|
2016
Q2 | $133M | Sell |
550,717
-258,258
| -32% | -$62.5M | 0.17% | 123 |
|
2016
Q1 | $211M | Sell |
808,975
-288,772
| -26% | -$75.2M | 0.27% | 79 |
|
2015
Q4 | $336M | Buy |
1,097,747
+8,756
| +0.8% | +$2.68M | 0.43% | 47 |
|
2015
Q3 | $318M | Buy |
1,088,991
+508,272
| +88% | +$148M | 0.43% | 48 |
|
2015
Q2 | $235M | Buy |
580,719
+53,079
| +10% | +$21.4M | 0.29% | 72 |
|
2015
Q1 | $223M | Sell |
527,640
-14,713
| -3% | -$6.21M | 0.29% | 77 |
|
2014
Q4 | $184M | Sell |
542,353
-512,662
| -49% | -$174M | 0.24% | 88 |
|
2014
Q3 | $349M | Sell |
1,055,015
-107,411
| -9% | -$35.5M | 0.49% | 40 |
|
2014
Q2 | $367M | Buy |
1,162,426
+418,438
| +56% | +$132M | 0.49% | 37 |
|
2014
Q1 | $228M | Buy |
743,988
+80,277
| +12% | +$24.6M | 0.33% | 66 |
|
2013
Q4 | $186M | Sell |
663,711
-18,505
| -3% | -$5.17M | 0.28% | 86 |
|
2013
Q3 | $164M | Buy |
682,216
+30,462
| +5% | +$7.33M | 0.27% | 83 |
|
2013
Q2 | $140M | Buy |
+651,754
| New | +$140M | 0.25% | 90 |
|